Nuclear Translocation of Calpain-2 Mediates Apoptosis of Hypertrophied Cardiomyocytes in Transverse Aortic Constriction Rat

Journal of Cellular Physiology

Volumn 230, Issue 11, 2015, Pages 2743-2754

  Sheng, Juan Juan ^a   Chang, Hui ^a   Yu, Zhi Bin ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN II; CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE II; CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE II DELTA B; CALCIUM ION; CALPAIN 1; CALPAIN 2; CALPASTATIN; CYTOCHROME C; MESSENGER RNA; PROTEIN BCL 2; UNCLASSIFIED DRUG; CALPAIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA CONSTRICTION; APOPTOSIS; ARTICLE; CALCIUM CELL LEVEL; CELL COUNT; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DISEASE DURATION; DOWN REGULATION; ENDOTHELIAL DYSFUNCTION; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME REPRESSION; GENE TRANSLOCATION; HEART DEPOLARIZATION; HEART EJECTION FRACTION; HEART FUNCTION; HEART LEFT VENTRICLE HYPERTROPHY; HEART MUSCLE CELL; HEART VENTRICLE WALL; HORMONE INHIBITION; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; PROTEIN SECRETION; RAT; SIGNAL TRANSDUCTION; TRANSVERSE ABDOMINAL AORTIC CONSTRICTION; UPREGULATION; ANIMAL; CARDIOMEGALY; GENE EXPRESSION REGULATION; GENETICS; HUMAN; METABOLISM; PATHOLOGY; STENOSIS, OCCLUSION AND OBSTRUCTION;

RATTUS;

ANGIOTENSIN II; ANIMALS; APOPTOSIS; CALCIUM-CALMODULIN-DEPENDENT PROTEIN KINASE TYPE 2; CALPAIN; CARDIOMEGALY; CONSTRICTION, PATHOLOGIC; GENE EXPRESSION REGULATION; HUMANS; MYOCYTES, CARDIAC; RATS; SIGNAL TRANSDUCTION;

EID: 84937851231     PISSN: 00219541     EISSN: 10974652     Source Type: Journal    
DOI: 10.1002/jcp.24999     Document Type: Article

References (33)

1. Arthur GD, Belcastro AN. 1997. A calcium stimulated cysteine protease involved in isoproterenol induced cardiac hypertrophy. Mol Cell Biochem 176:241-248.
2. Baghdiguian S, Martin M, Richard I, Pons F, Astier C, Bourg N, Hay RT, Chemaly R, Halaby G, Loiselet J, Anderson LV, Lopez DMA, Fardeau M, Mangeat P, Beckmann JS, Lefranc G. 1999. Calpain 3 deficiency is associated with myonuclear apoptosis and profound perturbation of the IkappaB alpha/NF-kappaB pathway in limb-girdle muscular dystrophy type 2A. Nat Med 5:503-511.
3. Bajaj G, Sharma RK. 2006. TNF-alpha-mediated cardiomyocyte apoptosis involves caspase-12 and calpain. Biochem Biophys Res Commun 345:1558-1564.
4. Boivin B, Chevalier D, Villeneuve LR, Rousseau E, Allen BG. 2003. Functional endothelin receptors are present on nuclei in cardiac ventricular myocytes. J Biol Chem 278:29153-29163.
5. Burkard N, Becher J, Heindl C, Neyses L, Schuh K, Ritter O. 2005. Targeted proteolysis sustains calcineurin activation. Circulation 111:1045-1053.
6. Chang H, Zhang L, Xu PT, Li Q, Sheng JJ, Wang YY, Chen Y, Zhang LN, Yu ZB. 2011. Nuclear translocation of calpain-2 regulates propensity toward apoptosis in cardiomyocytes of tail-suspended rats. J Cell Biochem 112:571-580.
7. Chen M, He H, Zhan S, Krajewski S, Reed JC, Gottlieb RA. 2001. Bid is cleaved by calpain to an active fragment in vitro and during myocardial ischemia/reperfusion. J Biol Chem 276:30724-30728.
8. Condorelli G, Morisco C, Stassi G, Notte A, Farina F, Sgaramella G, de Rienzo A, Roncarati R, Trimarco B, Lembo G. 1999. Increased cardiomyocyte apoptosis and changes in proapoptotic and antiapoptotic genes bax and bcl-2 during left ventricular adaptations to chronic pressure overload in the rat. Circulation 99:3071-3078.
9. Dostal DE, Hunt RA, Kule CE, Bhat GJ, Karoor V, McWhinney CD, Baker KM. 1997. Molecular mechanisms of angiotensin II in modulating cardiac function: Intracardiac effects and signal transduction pathways. J Mol Cell Cardiol 29:2893-2902.
10. Freund C, Schmidt-Ullrich R, Baurand A, Dunger S, Schneider W, Loser P, El-Jamali A, Dietz R, Scheidereit C, Bergmann MW. 2005. Requirement of nuclear factor-kappaB in angiotensin II- and isoproterenol-induced cardiac hypertrophy in vivo. Circulation 111:2319-2325.
11. Fujita T, Ishikawa Y. 2011. Apoptosis in heart failure. The role of the beta-adrenergic receptor-mediated signaling pathway and p53-mediated signaling pathway in the apoptosis of cardiomyocytes. Circ J 75:1811-1818.
12. Futai E, Kubo T, Sorimachi H, Suzuki K, Maeda T. 2001. Molecular cloning of PalBH, a mammalian homologue of the Aspergillus atypical calpain PalB. Biochim Biophys Acta 1517:316-319.
13. Galvez AS, Diwan A, Odley AM, Hahn HS, Osinska H, Melendez JG, Robbins J, Lynch RA, Marreez Y, Dorn GN. 2007. Cardiomyocyte degeneration with calpain deficiency reveals a critical role in protein homeostasis. Circ Res 100:1071-1078.
14. Goll DE, Thompson VF, Li H, Wei W, Cong J. 2003. The calpain system. Physiol Rev 83:731-801.
15. Gutkowska J, Paquette A, Wang D, Lavoie JM, Jankowski M. 2007. Effect of exercise training on cardiac oxytocin and natriuretic peptide systems in ovariectomized rats. Am J Physiol Regul Integr Comp Physiol 293:R267-R275.
16. +-ATPase activity during early reperfusion. Cardiovasc Res 70:364-373.
17. Jiang L, Wang M, Zhang J, Monticone RE, Telljohann R, Spinetti G, Pintus G, Lakatta EG. 2008. Increased aortic calpain-1 activity mediates age-associated angiotensin II signaling of vascular smooth muscle cells. PLoS One 3:e2231.
18. Lane RD, Allan DM, Mellgren RL. 1992. A comparison of the intracellular distribution of mu-calpain, m-calpain, and calpastatin in proliferating human A431 cells. Exp Cell Res 203:5-16.
19. Letavernier E, Perez J, Bellocq A, Mesnard L, de Castro KA, Haymann JP, Baud L. 2008. Targeting the calpain/calpastatin system as a new strategy to prevent cardiovascular remodeling in angiotensin II-induced hypertension. Circ Res 102:720-728.
20. Letavernier E, Zafrani L, Perez J, Letavernier B, Haymann JP, Baud L. 2012. The role of calpains in myocardial remodelling and heart failure. Cardiovasc Res 96:38-45.
21. Li Y, Li Y, Feng Q, Arnold M, Peng T. 2009. Calpain activation contributes to hyperglycaemia-induced apoptosis in cardiomyocytes. Cardiovasc Res 84:100-110.
22. Li Z, Bing OH, Long X, Robinson KG, Lakatta EG. 1997. Increased cardiomyocyte apoptosis during the transition to heart failure in the spontaneously hypertensive rat. Am J Physiol 272:H2313-H2319.
23. Little GH, Saw A, Bai Y, Dow J, Marjoram P, Simkhovich B, Leeka J, Kedes L, Kloner RA, Poizat C. 2009. Critical role of nuclear calcium/calmodulin-dependent protein kinase IIdeltaB in cardiomyocyte survival in cardiomyopathy. J Biol Chem 284:24857-24868.
24. Ma XW, Li Q, Xu PT, Zhang L, Li H, Yu ZB. 2011. Tetanic contractions impair sarcomeric Z-disk of atrophic soleus muscle via calpain pathway. Mol Cell Biochem 354:171-180.
25. 2+ activation of diffusible and bound pools of mu-calpain in rat skeletal muscle. J Physiol 576:595-612.
26. Peng W, Zhang Y, Zheng M, Cheng H, Zhu W, Cao CM, Xiao RP. 2010. Cardioprotection by CaMKII-deltaB is mediated by phosphorylation of heat shock factor 1 and subsequent expression of inducible heat shock protein 70. Circ Res 106:102-110.
27. Scalia R, Gong Y, Berzins B, Freund B, Feather D, Landesberg G, Mishra G. 2011. A novel role for calpain in the endothelial dysfunction induced by activation of angiotensin II type 1 receptor signaling. Circ Res 108:1102-1111.
28. Sheng JJ, Chen Y, Chang H, Wang YY, Jiao B, Yu ZB. 2014. Multisite phosphorylation of Bcl-2 via protein kinase Cdelta facilitates apoptosis of hypertrophic cardiomyocytes. Clin Exp Pharmacol Physiol 41:891-901.
29. Suzuki J, Matsubara H, Urakami M, Inada M. 1993. Rat angiotensin II (type 1A) receptor mRNA regulation and subtype expression in myocardial growth and hypertrophy. Circ Res 73:439-447.
30. Willis MS, Schisler JC, Portbury AL, Patterson C. 2009. Build it up-Tear it down: Protein quality control in the cardiac sarcomere. Cardiovasc Res 81:439-448.
31. Xu PT, Li Q, Sheng JJ, Chang H, Song Z, Yu ZB. 2012. Passive stretch reduces calpain activity through nitric oxide pathway in unloaded soleus muscles. Mol Cell Biochem 367:113-124.
32. Yu ZB, Wei H, Jin JP. 2012. Chronic coexistence of two troponin T isoforms in adult transgenic mouse cardiomyocytes decreased contractile kinetics and caused dilatative remodeling. Am J Physiol Cell Physiol 303:C24-C32.
33. Zhang WB, Du QJ, Li H, Sun AJ, Qiu ZH, Wu CN, Zhao G, Gong H, Hu K, Zou YZ, Ge JB. 2012. The therapeutic effect of rosuvastatin on cardiac remodelling from hypertrophy to fibrosis during the end-stage hypertension in rats. J Cell Mol Med 16:2227-2237.